Diabetes mellitus, the fastest growing global public health concern: Early detection should be focused

• Published in: Health science reports 2024-03, Vol.7 (3), p.e2004-n/a
• Main Authors: Hossain, Md Jamal, Al-Mamun, Md, Islam, Md Rabiul
• Format: Article
• Language: English
• Subjects: Coronaviruses; COVID-19; Diabetes; early diagnosis; Exercise; Global health; global public health concern; International Diabetes Federation (IDF); low and middle‐income countries (LMICs); Medical diagnosis; Mortality; Type 2 Diabetes Miletus
• ISSN: 2398-8835; 2398-8835
• DOI: 10.1002/hsr2.2004

Diabetes is recognized as a significant factor in both mortality and morbidity worldwide, affecting various demographics regardless of geographic location, age group, or gender. This correspondence aims to express concern and draw the attention of leaders and policymakers worldwide to this critical public health issue. A thorough literature search was conducted utilizing various databases, including Google Scholar, PubMed, Science Direct, and the International Diabetes Federation (IDF) website, to collect the required data. Keywords were strategically applied to enhance search results, with preference given to English-language articles containing pertinent information. According to the 2021 report by the IDF, approximately 537 million individuals globally were affected with diabetes, constituting roughly 10.5% of the world's populace. This condition incurred healthcare expenditures totaling $966 billion. Projections indicate a surge in diabetes cases to 783 million by 2045, with associated healthcare costs estimated to surpass $1054 billion. However, almost half of all people with diabetes are unaware of their medical condition, with the highest prevalence of undiagnosed diabetes Mellitus (DM) found in low and middle-income countries (LMICs) of the regions of Africa, the Western Pacific, and Southeast Asia. Collaborating with the World Health Organization (WHO), LMIC governments should improve healthcare accessibility, including more frequent diabetes screenings for individuals aged ≥ 45 years and younger individuals at elevated risk of having a family history.